Viatris Chief Legal Officer Receives 59,323 RSU Grant
Viatris Inc
Subscribe to track VTRS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Viatris Chief Legal Officer Receives 59,323 RSU Grant
Company: Viatris Inc ([VTRS]) Form: 4 | Filed: 2026-03-10 Significance: Low
Insider: Maletta Matthew Joseph Title: Chief Legal Officer | Relationship: Officer
Transaction: • Type: Grant (Award) • Shares: 59,323 • Price: $0.00 • Value: $0.00 (Compensation Grant) • Owned After: 59,323
Key Insight: Routine executive compensation grant of Restricted Stock Units (RSUs) with a 3-year vesting schedule.
Market Context: Transaction represents negligible dilution (0.005% of outstanding shares) for this $17.19B market cap company.
Comprehensive Analysis
SEC Filing Analysis: Viatris Inc (VTRS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Chief Legal Officer receives standard annual equity compensation in the form of Restricted Stock Units.
- Market Impact: Neutral - Routine compensation event with negligible dilution.
Company Information
| Field | Value |
|---|---|
| Company | Viatris Inc |
| Ticker Symbol | VTRS |
| CIK | 0001792044 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Maletta Matthew Joseph |
| CIK | 0001639765 |
| Title/Position | Chief Legal Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-06 |
| Transaction Code | A (Grant/Award) |
| Security Type | Restricted Stock Units |
| Shares Involved | 59,323 |
| Price Per Share | $0.00 |
| Total Value | $0.00 (Grant) |
| Shares Owned After | 59,323 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0.00 (Grant) |
| % of Market Cap | 0.00% |
| Shares Transacted | 59,323 |
| % of Shares Outstanding | 0.005% |
| Post-Transaction Ownership | 59,323 shares (0.005% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Viatris is a Large Cap company ($17.19B). This equity grant is standard for a company of this size.
- Dilution Impact: The grant represents approximately 0.005% of the 1.15 billion shares outstanding, resulting in virtually zero dilution impact for shareholders.
- Transaction Significance: As a compensation award with $0 cost basis to the insider, this does not reflect an open-market investment decision.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a scheduled compensation event (Code A) rather than an open market purchase (Code P) or sale (Code S). It provides no signal regarding the insider's sentiment on stock valuation.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Vesting Schedule: The RSUs vest in three equal annual installments beginning March 6, 2027.
- Security Nature: Each RSU represents the right to receive one share of common stock upon vesting.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.